EE200300468A - Pravastatiini stabiilne farmatseutiline kompositsioon - Google Patents
Pravastatiini stabiilne farmatseutiline kompositsioonInfo
- Publication number
- EE200300468A EE200300468A EEP200300468A EEP200300468A EE200300468A EE 200300468 A EE200300468 A EE 200300468A EE P200300468 A EEP200300468 A EE P200300468A EE P200300468 A EEP200300468 A EE P200300468A EE 200300468 A EE200300468 A EE 200300468A
- Authority
- EE
- Estonia
- Prior art keywords
- pravastatin
- pharmaceutical composition
- stable pharmaceutical
- stable
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN375DE2001 | 2001-03-27 | ||
PCT/IB2002/000882 WO2002076376A2 (fr) | 2001-03-27 | 2002-03-22 | Composition pharmaceutique stable a base de pravastatine |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200300468A true EE200300468A (et) | 2004-02-16 |
Family
ID=29560486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300468A EE200300468A (et) | 2001-03-27 | 2002-03-22 | Pravastatiini stabiilne farmatseutiline kompositsioon |
Country Status (17)
Country | Link |
---|---|
US (1) | US20040157925A1 (fr) |
EP (1) | EP1372616A4 (fr) |
JP (1) | JP2004527518A (fr) |
KR (1) | KR20030096294A (fr) |
CN (1) | CN1240377C (fr) |
BR (1) | BR0208504A (fr) |
CA (1) | CA2442280A1 (fr) |
CZ (1) | CZ20032828A3 (fr) |
EE (1) | EE200300468A (fr) |
HU (1) | HUP0401234A2 (fr) |
MX (1) | MXPA03008837A (fr) |
NZ (1) | NZ528543A (fr) |
PL (1) | PL369268A1 (fr) |
RU (1) | RU2003131338A (fr) |
SK (1) | SK13022003A3 (fr) |
WO (1) | WO2002076376A2 (fr) |
ZA (1) | ZA200308256B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003055217A (ja) * | 2001-08-10 | 2003-02-26 | Taiyo Yakuhin Kogyo Kk | 医薬組成物 |
CA2465693A1 (fr) * | 2003-06-12 | 2004-12-12 | Warner-Lambert Company Llc | Compositions pharmaceutiques d'atorvastatine |
EP1651194B1 (fr) * | 2003-08-06 | 2010-03-31 | Galephar M/F | Compositions pharmaceutiques stables a liberation controlee contenant du fenofibrate et de la pravastatine |
WO2006008757A2 (fr) * | 2004-05-05 | 2006-01-26 | Cadila Healthcare Limited | Compositions pharmaceutiques stabilisees contenant de la pravastatine |
ATE549399T1 (de) * | 2006-12-13 | 2012-03-15 | Dsm Sinochem Pharm Nl Bv | Verfahren zur herstellung von pravastatin |
CA2691956A1 (fr) * | 2007-06-25 | 2008-12-31 | Pharmathen S.A. | Formulation pharmaceutique amelioree contenant un inhibiteur de la hmg-coa reductase et son procede de preparation |
GB0713707D0 (en) * | 2007-07-13 | 2007-08-22 | Generics Uk Ltd | Stable compositions |
JPWO2011049122A1 (ja) * | 2009-10-21 | 2013-03-14 | 第一三共株式会社 | プラバスタチンナトリウム口腔内速崩壊錠及びその製造方法 |
JP5988963B2 (ja) * | 2011-04-12 | 2016-09-07 | 沢井製薬株式会社 | ピタバスタチン含有製剤及びその製造方法 |
SI2827845T1 (sl) | 2012-03-22 | 2019-04-30 | Novo Nordisk A/S | Sestavki, ki obsegajo dostavno sredstvo in njihova priprava |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK149080C (da) * | 1980-06-06 | 1986-07-28 | Sankyo Co | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
US5225202A (en) * | 1991-09-30 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Enteric coated pharmaceutical compositions |
NO318765B1 (no) * | 1995-07-03 | 2005-05-02 | Sankyo Co | Anvendelse av en HMG-CoA reduktaseinhibitor og en insulinsensibilisator til fremstilling av et medikament for forebyggelse eller behandling av arteriosklerose eller xantom, samt pakket farmasoytisk preparat som omfatter de to midlene i separate porsjoner. |
US6235311B1 (en) * | 1998-03-18 | 2001-05-22 | Bristol-Myers Squibb Company | Pharmaceutical composition containing a combination of a statin and aspirin and method |
SI20109A (sl) * | 1998-12-16 | 2000-06-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Stabilna farmacevtska formulacija |
-
2002
- 2002-03-22 KR KR10-2003-7012675A patent/KR20030096294A/ko not_active Application Discontinuation
- 2002-03-22 EP EP02716958A patent/EP1372616A4/fr not_active Withdrawn
- 2002-03-22 CZ CZ20032828A patent/CZ20032828A3/cs unknown
- 2002-03-22 BR BR0208504-6A patent/BR0208504A/pt not_active IP Right Cessation
- 2002-03-22 MX MXPA03008837A patent/MXPA03008837A/es not_active Application Discontinuation
- 2002-03-22 HU HU0401234A patent/HUP0401234A2/hu unknown
- 2002-03-22 NZ NZ528543A patent/NZ528543A/en unknown
- 2002-03-22 PL PL02369268A patent/PL369268A1/xx not_active Application Discontinuation
- 2002-03-22 JP JP2002574892A patent/JP2004527518A/ja not_active Withdrawn
- 2002-03-22 CN CNB028093542A patent/CN1240377C/zh not_active Expired - Fee Related
- 2002-03-22 EE EEP200300468A patent/EE200300468A/xx unknown
- 2002-03-22 CA CA002442280A patent/CA2442280A1/fr not_active Abandoned
- 2002-03-22 RU RU2003131338/15A patent/RU2003131338A/ru not_active Application Discontinuation
- 2002-03-22 WO PCT/IB2002/000882 patent/WO2002076376A2/fr not_active Application Discontinuation
- 2002-03-22 SK SK1302-2003A patent/SK13022003A3/sk unknown
-
2003
- 2003-10-23 ZA ZA200308256A patent/ZA200308256B/en unknown
-
2004
- 2004-04-12 US US10/473,208 patent/US20040157925A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ZA200308256B (en) | 2004-08-12 |
NZ528543A (en) | 2005-07-29 |
CN1240377C (zh) | 2006-02-08 |
RU2003131338A (ru) | 2005-02-10 |
SK13022003A3 (sk) | 2004-03-02 |
WO2002076376A3 (fr) | 2003-01-09 |
CN1518443A (zh) | 2004-08-04 |
EP1372616A2 (fr) | 2004-01-02 |
JP2004527518A (ja) | 2004-09-09 |
US20040157925A1 (en) | 2004-08-12 |
HUP0401234A2 (hu) | 2004-11-29 |
BR0208504A (pt) | 2004-03-09 |
CZ20032828A3 (en) | 2004-07-14 |
MXPA03008837A (es) | 2004-05-05 |
CA2442280A1 (fr) | 2002-10-03 |
PL369268A1 (en) | 2005-04-18 |
EP1372616A4 (fr) | 2004-06-23 |
WO2002076376A2 (fr) | 2002-10-03 |
KR20030096294A (ko) | 2003-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI20011478A (fi) | Farmaseuttinen koostumus | |
NO20033556L (no) | Farmasöytiske formuleringer | |
NO20033384D0 (no) | Farmasöytisk formulering | |
ATE296619T1 (de) | Feste orale dosierungsform von simethicon | |
AR028204A1 (es) | Composiciones farmaceuticas electrohiladas | |
FI20001750A0 (fi) | Farmaseuttisia koostumuksia | |
IS7714A (is) | Lyfjasamsetningar úr módafíníl | |
ITMI20010748A0 (it) | Composizioni farmaceutiche | |
NO20033785D0 (no) | Farmasöytisk formulering | |
DK1395242T3 (da) | Flydende farmaceutisk sammensætning | |
EE05020B1 (et) | Glburiidi ravimkoostis | |
DK1458377T3 (da) | Farmaceutiske sammensætninger indeholdende tegaserod | |
IS7051A (is) | Lyfjasamsetningar | |
NO20035627D0 (no) | Farmasöytisk formulering | |
NO20026123L (no) | Farmasöytiske sammensetninger | |
FI20022128A0 (fi) | Farmaseuttinen koostumus | |
ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
EE200300468A (et) | Pravastatiini stabiilne farmatseutiline kompositsioon | |
DK1475379T3 (da) | Anvendelse af scopinesterderivater til fremstilling af lægemidler | |
EP1404303A4 (fr) | Compositions pharmaceutiques stables a base de pravastatine | |
DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
ATE350029T1 (de) | Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain | |
NO20033073L (no) | Farmasöytisk sammensetning inneholdende citalopram | |
DE10107261B4 (de) | Pharmazeutische Zusammensetzung | |
NO20041236L (no) | Farmasoytisk formulering |